{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:44:51Z","timestamp":1792518291534,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T00:00:00Z","timestamp":1716163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102017"],"award-info":[{"award-number":["82102017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["21YF1407800"],"award-info":[{"award-number":["21YF1407800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00259-024-06761-3","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T07:01:37Z","timestamp":1716188497000},"page":"3440-3449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["[68Ga]Ga-FAPI-04 PET\/MR imaging strategy in management of Krukenberg tumors (KTs) from gastric signet-ring-cell carcinoma: to overcome limitation of [68Ga]Ga-FAPI-04 PET imaging in KTs"],"prefix":"10.1007","volume":"51","author":[{"given":"Tingting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-1972","authenticated-orcid":false,"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"key":"6761_CR1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3892\/mco.2015.634","volume":"3","author":"F Wu","year":"2015","unstructured":"Wu F, Zhao X, Mi B, Feng L, Yuan N, Lei F, et al. Clinical characteristics and prognostic analysis of Krukenberg tumor. Mol Clin Oncol. 2015;3:1323\u20138.","journal-title":"Mol Clin Oncol"},{"key":"6761_CR2","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.21037\/jgo-22-464","volume":"13","author":"X Lin","year":"2022","unstructured":"Lin X, Han T, Zhuo M, Liu T, Liu Z, Xiang D, et al. A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin. J Gastrointest Oncol. 2022;13:1022\u201334.","journal-title":"J Gastrointest Oncol"},{"key":"6761_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ygyno.2004.05.007","volume":"94","author":"JH Cheong","year":"2004","unstructured":"Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol. 2004;94:477\u201382.","journal-title":"Gynecol Oncol"},{"key":"6761_CR4","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.7150\/jca.25593","volume":"9","author":"D Yan","year":"2018","unstructured":"Yan D, Du Y, Dai G, Huang L, Xu Q, Yu P. Management of Synchronous Krukenberg Tumors from gastric Cancer: a single-center experience. J Cancer. 2018;9:4197\u2013203.","journal-title":"J Cancer"},{"key":"6761_CR5","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.2147\/CMAR.S227684","volume":"11","author":"F Ma","year":"2019","unstructured":"Ma F, Li Y, Li W, Kang W, Liu H, Ma S, et al. Metastasectomy improves the survival of gastric Cancer patients with Krukenberg Tumors: a retrospective analysis of 182 patients. Cancer Manag Res. 2019;11:10573\u201380.","journal-title":"Cancer Manag Res"},{"key":"6761_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"W-L Guan","year":"2023","unstructured":"Guan W-L, He Y, Xu R-H. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16:57.","journal-title":"J Hematol Oncol"},{"key":"6761_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejso.2008.05.006","volume":"35","author":"R Jiang","year":"2009","unstructured":"Jiang R, Tang J, Cheng X, Zang RY. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors. Eur J Surg Oncol (EJSO). 2009;35:92\u20137.","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"6761_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00004728-199605000-00013","volume":"20","author":"SH Kim","year":"1996","unstructured":"Kim SH, Kim WH, Park KJ, Lee JK, Kim JS. CT and MR findings of Krukenberg tumors: comparison with primary ovarian tumors. J Comput Assist Tomogr. 1996;20:393\u20138.","journal-title":"J Comput Assist Tomogr"},{"key":"6761_CR9","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2214\/ajr.164.6.7754887","volume":"164","author":"HK Ha","year":"1995","unstructured":"Ha HK, Baek SY, Kim SH, Kim HH, Chung EC, Yeon KM. Krukenberg\u2019s tumor of the ovary: MR imaging features. Am J Roentgenol. 1995;164:1435\u20139.","journal-title":"Am J Roentgenol"},{"key":"6761_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.21037\/jgo-20-364","volume":"12","author":"H Xie","year":"2021","unstructured":"Xie H, Erickson BJ, Sheedy SP, Yin J, Hubbard JM. The diagnosis and outcome of Krukenberg tumors. J Gastrointest Oncol. 2021;12:226\u201336.","journal-title":"J Gastrointest Oncol"},{"key":"6761_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2214\/AJR.19.22184","volume":"215","author":"M Zulfiqar","year":"2020","unstructured":"Zulfiqar M, Koen J, Nougaret S, Bolan C, VanBuren W, McGettigan M, et al. Krukenberg tumors: Update on Imaging and Clinical features. Am J Roentgenol. 2020;215:1020\u20139.","journal-title":"Am J Roentgenol"},{"key":"6761_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00428-015-1771-2","volume":"467","author":"J Bruls","year":"2015","unstructured":"Bruls J, Simons M, Overbeek LI, Bulten J, Massuger LF, Nagtegaal ID. A national population-based study provides insight in the origin of malignancies metastatic to the ovary. Virchows Arch. 2015;467:79\u201386.","journal-title":"Virchows Arch"},{"key":"6761_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2967\/jnumed.114.150946","volume":"56","author":"Y Kaneko","year":"2015","unstructured":"Kaneko Y, Murray WK, Link E, Hicks RJ, Duong C. Improving patient selection for 18 F-FDG PET scanning in the staging of gastric Cancer. J Nucl Med. 2015;56:523\u20139.","journal-title":"J Nucl Med"},{"key":"6761_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/MNM.0000000000001481","volume":"42","author":"F Dondi","year":"2021","unstructured":"Dondi F, Albano D, Giubbini R, Bertagna F. 18F-FDG PET and PET\/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review. Nucl Med Commun. 2021;42:1293\u2013300.","journal-title":"Nucl Med Commun"},{"key":"6761_CR15","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1007\/s00259-022-05799-5","volume":"49","author":"R Lin","year":"2022","unstructured":"Lin R, Lin Z, Chen Z, Zheng S, Zhang J, Zang J, et al. [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2022;49:2960\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6761_CR16","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s00259-021-05441-w","volume":"49","author":"D Jiang","year":"2022","unstructured":"Jiang D, Chen X, You Z, Wang H, Zhang X, Li X, et al. Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study. Eur J Nucl Med Mol Imaging. 2022;49:732\u201342.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6761_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1148\/radiol.2020203275","volume":"298","author":"Y Pang","year":"2021","unstructured":"Pang Y, Zhao L, Luo Z, Hao B, Wu H, Lin Q, et al. Comparison of 68 Ga-FAPI and 18 F-FDG uptake in gastric, duodenal, and colorectal cancers. Radiology. 2021;298:393\u2013402.","journal-title":"Radiology"},{"key":"6761_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00259-021-05494-x","volume":"49","author":"J Kuten","year":"2022","unstructured":"Kuten J, Levine C, Shamni O, Pelles S, Wolf I, Lahat G, et al. Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET\/CT in evaluating the extent of disease in gastric adenocarcinoma. Eur J Nucl Med Mol Imaging. 2022;49:743\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6761_CR19","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s00330-022-09251-y","volume":"33","author":"C Li","year":"2022","unstructured":"Li C, Tian Y, Chen J, Jiang Y, Xue Z, Xing D, et al. Usefulness of [68Ga]FAPI-04 and [18F]FDG PET\/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study. Eur Radiol. 2022;33:2779\u201391.","journal-title":"Eur Radiol"},{"key":"6761_CR20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00330-022-09084-9","volume":"33","author":"H Chen","year":"2022","unstructured":"Chen H, Pang Y, Li J, Kang F, Xu W, Meng T, et al. Comparison of [68Ga]Ga-FAPI and [18F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study. Eur Radiol. 2022;33:1329\u201341.","journal-title":"Eur Radiol"},{"issue":"2","key":"6761_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(2):167\u201392.","journal-title":"J Natl Compr Canc Netw"},{"issue":"08","key":"6761_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.19538\/j.fk2023080111","volume":"39","author":"Z Zhang Yi","year":"2023","unstructured":"Zhang Yi Z, Shiqian S, Wenjing, et al. Chinese expert Consensus on diagnosis and treatment of ovarian metastases in gastrointestinal malignancies (2023). Chin J Practical Gynecol Ang Obstet. 2023;39(08):817\u201323. https:\/\/doi.org\/10.19538\/j.fk2023080111.","journal-title":"Chin J Practical Gynecol Ang Obstet"},{"key":"6761_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of Quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59:1415\u201322.","journal-title":"J Nucl Med"},{"issue":"3","key":"6761_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1148\/radiol.213118","volume":"304","author":"L Lan","year":"2022","unstructured":"Lan L, Zhang S, Xu T, Liu H, Wang W, Feng Y, Wang L, Chen Y, Qiu L. Prospective comparison of 68Ga-FAPI versus 18F-FDG PET\/CT for Tumor staging in biliary tract cancers. Radiology. 2022;304(3):648\u201357.","journal-title":"Radiology"},{"key":"6761_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2967\/jnumed.120.258467","volume":"63","author":"C Qin","year":"2022","unstructured":"Qin C, Shao F, Gai Y, Liu Q, Ruan W, Liu F, et al. 68 Ga-DOTA-FAPI-04 PET\/MR in the evaluation of gastric carcinomas: comparison with 18 F-FDG PET\/CT. J Nucl Med. 2022;63:81\u20138.","journal-title":"J Nucl Med"},{"key":"6761_CR26","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1007\/s00330-022-09321-1","volume":"33","author":"Y Miao","year":"2022","unstructured":"Miao Y, Feng R, Guo R, Huang X, Hai W, Li J, et al. Utility of [68Ga]FAPI-04 and [18F]FDG dual-tracer PET\/CT in the initial evaluation of gastric cancer. Eur Radiol. 2022;33:4355\u201366.","journal-title":"Eur Radiol"},{"key":"6761_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MNM.0000000000001653","volume":"44","author":"W Zheng","year":"2023","unstructured":"Zheng W, Liu L, Feng Y, Wang L, Chen Y. Comparison of 68Ga-FAPI-04 and fluorine-18-fluorodeoxyglucose PET\/computed tomography in the detection of ovarian malignancies. Nucl Med Commun. 2023;44:194\u2013203.","journal-title":"Nucl Med Commun"},{"key":"6761_CR28","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","volume":"48","author":"K Dendl","year":"2021","unstructured":"Dendl K, Koerber SA, Finck R, Mokoala KMG, Staudinger F, Schillings L, et al. 68Ga-FAPI-PET\/CT in patients with various gynecological malignancies. Eur J Nucl Med Mol Imaging. 2021;48:4089\u2013100.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6761_CR29","doi-asserted-by":"publisher","first-page":"748683","DOI":"10.3389\/fmed.2021.748683","volume":"8","author":"Q Wang","year":"2021","unstructured":"Wang Q, Yang S, Tang W, Liu L, Chen Y. 68Ga-DOTA-FAPI-04 PET\/CT as a Promising Tool for differentiating ovarian physiological uptake: preliminary experience of comparative analysis with 18F-FDG. Front Med. 2021;8:748683.","journal-title":"Front Med"},{"key":"6761_CR30","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1007\/s00259-023-06369-z","volume":"50","author":"J Chen","year":"2023","unstructured":"Chen J, Xu K, Li C, Tian Y, Li L, Wen B, et al. [68Ga]Ga-FAPI-04 PET\/CT in the evaluation of epithelial ovarian cancer: comparison with [18F]F-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2023;50:4064\u201376.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6761_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41416-022-01748-z","volume":"127","author":"E Strating","year":"2022","unstructured":"Strating E, Wassenaar E, Verhagen M, Rauwerdink P, Van Schelven S, De Hingh I, et al. Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by 68Ga-FAPI-PET imaging. Br J Cancer. 2022;127:145\u201355.","journal-title":"Br J Cancer"},{"key":"6761_CR32","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, Fu K, Yang T, Zhao L, et al. Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021;48:1944\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6761_CR33","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00261-007-9186-4","volume":"32","author":"T Koyama","year":"2007","unstructured":"Koyama T, Mikami Y, Saga T, Tamai K, Togashi K. Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation. Abdom Imaging. 2007;32:784\u201395.","journal-title":"Abdom Imaging"},{"key":"6761_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00404-019-05167-z","volume":"300","author":"R Lionetti","year":"2019","unstructured":"Lionetti R, De Luca M, Travaglino A, Raffone A, Insabato L, Saccone G, et al. Treatments and overall survival in patients with Krukenberg tumor. Arch Gynecol Obstet. 2019;300:15\u201323.","journal-title":"Arch Gynecol Obstet"},{"issue":"47","key":"6761_CR35","doi-asserted-by":"publisher","first-page":"82558","DOI":"10.18632\/oncotarget.19759","volume":"8","author":"P Yu","year":"2017","unstructured":"Yu P, Huang L, Cheng G, Yang L, Dai G, Ying J, Du Y. Treatment strategy and prognostic factors for Krukenberg tumors of gastric origin: report of a 10-year single-center experience from China. Oncotarget. 2017;8(47):82558\u201370.","journal-title":"Oncotarget"},{"key":"6761_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10585-017-9856-8","volume":"34","author":"O Kube\u010dek","year":"2017","unstructured":"Kube\u010dek O, Laco J, \u0160pa\u010dek J, Petera J, Kopeck\u00fd J, Kube\u010dkov\u00e1 A, et al. The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. Clin Exp Metastas. 2017;34:295\u2013307.","journal-title":"Clin Exp Metastas"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-06761-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T19:03:29Z","timestamp":1725303809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-06761-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["6761"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-06761-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were approved by the Institutional Review Board of Shanghai Jiao Tong University-affiliated Ren Ji Hospital and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This article does not describe any studies with animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}